Bank Hapoalim BM’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.08M | Buy |
109,495
+41,100
| +60% | +$1.09M | 0.47% | 33 |
|
|
2025
Q4 | $1.7M | Sell |
68,395
-150
| -0.2% | -$3.78K | 0.15% | 57 |
|
|
2025
Q3 | $1.75M | Sell |
68,545
-42,710
| -38% | -$1.05M | 0.21% | 59 |
|
|
2025
Q2 | $2.7M | Sell |
111,255
-5,363
| -5% | -$125K | 0.37% | 50 |
|
|
2025
Q1 | $2.96M | Sell |
116,618
-2,500
| -2% | -$65.4K | 0.43% | 46 |
|
|
2024
Q4 | $3.16M | Sell |
119,118
-11,100
| -9% | -$301K | 0.51% | 46 |
|
|
2024
Q3 | $3.77M | Buy |
130,218
+2,901
| +2% | +$84.6K | 0.57% | 47 |
|
|
2024
Q2 | $3.56M | Sell |
127,317
-2,582
| -2% | -$71.1K | 0.5% | 50 |
|
|
2024
Q1 | $3.6M | Buy |
129,899
+107,148
| +471% | +$2.97M | 0.47% | 53 |
|
|
2023
Q4 | $655K | Sell |
22,751
-8,579
| -27% | -$259K | 0.09% | 113 |
|
|
2023
Q3 | $1.04M | Sell |
31,330
-32,796
| -51% | -$1.16M | 0.17% | 82 |
|
|
2023
Q2 | $2.35M | Sell |
64,126
-27,244
| -30% | -$1.06M | 0.34% | 65 |
|
|
2023
Q1 | $3.73M | Sell |
91,370
-45,332
| -33% | -$1.96M | 0.51% | 53 |
|
|
2022
Q4 | $7M | Sell |
136,702
-2,420
| -2% | -$116K | 0.87% | 40 |
|
|
2022
Q3 | $6.09M | Sell |
139,122
-67,210
| -33% | -$3.27M | 0.77% | 40 |
|
|
2022
Q2 | $10.8M | Sell |
206,332
-9,993
| -5% | -$509K | 1.35% | 26 |
|
|
2022
Q1 | $11.2M | Sell |
216,325
-10,420
| -5% | -$541K | 1.17% | 32 |
|
|
2021
Q4 | $13.4M | Buy |
226,745
+18,284
| +9% | +$906K | 1.34% | 23 |
|
|
2021
Q3 | $8.97M | Buy |
208,461
+140,673
| +208% | +$6.23M | 0.94% | 36 |
|
|
2021
Q2 | $2.65M | Sell |
67,788
-9,636
| -12% | -$375K | 0.3% | 73 |
|
|
2021
Q1 | $2.81M | Sell |
77,424
-41,771
| -35% | -$1.48M | 0.36% | 71 |
|
|
2020
Q4 | $4.39M | Buy |
119,195
+57,280
| +93% | +$2.1M | 0.61% | 45 |
|
|
2020
Q3 | $2.16K | Buy |
61,915
+3,425
| +6% | +$120K | 0.1% | 49 |
|
|
2020
Q2 | $1.81M | Sell |
58,490
-14,840
| -20% | -$504K | 0.42% | 55 |
|
|
2020
Q1 | $2.27M | Sell |
73,330
-6,277
| -8% | -$214K | 0.72% | 34 |
|
|
2019
Q4 | $2.96M | Sell |
79,607
-4,505
| -5% | -$160K | 0.65% | 30 |
|
|
2019
Q3 | $2.89M | Buy |
84,112
+343
| +0.4% | +$12.5K | 0.71% | 28 |
|
|
2019
Q2 | $3.44M | Buy |
83,769
+13,534
| +19% | +$537K | 0.85% | 30 |
|
|
2019
Q1 | $2.83M | Buy |
70,235
+4,313
| +7% | +$173K | 0.68% | 32 |
|
|
2018
Q4 | $2.73M | Sell |
65,922
-11,043
| -14% | -$458K | 0.88% | 31 |
|
|
2018
Q3 | $3.22M | Buy |
76,965
+216
| +0.3% | +$8.31K | 0.78% | 35 |
|
|
2018
Q2 | $2.64M | Buy |
76,749
+218
| +0.3% | +$7.45K | 0.72% | 36 |
|
|
2018
Q1 | $2.58M | Sell |
76,531
-27,383
| -26% | -$941K | 0.67% | 38 |
|
|
2017
Q4 | $3.57K | Sell |
103,914
-13,859
| -12% | -$473K | 0.78% | 30 |
|
|
2017
Q3 | $3.99M | Sell |
117,773
-9,409
| -7% | -$302K | 0.91% | 28 |
|
|
2017
Q2 | $4.05M | Sell |
127,182
-8,353
| -6% | -$263K | 0.96% | 26 |
|
|
2017
Q1 | $4.4M | Buy |
135,535
+2,579
| +2% | +$81.3K | 1.03% | 26 |
|
|
2016
Q4 | $4.1M | Buy |
132,956
+1,983
| +2% | +$60.5K | 1.09% | 24 |
|
|
2016
Q3 | $4.21M | Buy |
130,973
+6,562
| +5% | +$219K | 0.99% | 29 |
|
|
2016
Q2 | $4.16M | Buy |
124,411
+18,387
| +17% | +$587K | 0.97% | 32 |
|
|
2016
Q1 | $2.98M | Buy |
106,024
+4,638
| +5% | +$132K | 0.71% | 35 |
|
|
2015
Q4 | $3.1M | Buy |
101,386
+8,572
| +9% | +$270K | 0.71% | 34 |
|
|
2015
Q3 | $2.77M | Sell |
92,814
-16,350
| -15% | -$524K | 0.64% | 39 |
|
|
2015
Q2 | $3.47M | Sell |
109,164
-4,175
| -4% | -$136K | 0.68% | 37 |
|
|
2015
Q1 | $4.13M | Buy |
113,339
+5,136
| +5% | +$163K | 0.76% | 37 |
|
|
2014
Q4 | $3.2M | Sell |
108,203
-3,537
| -3% | -$101K | 0.68% | 30 |
|
|
2014
Q3 | $3.13M | Buy |
111,740
+3,019
| +3% | +$84.7K | 0.73% | 28 |
|
|
2014
Q2 | $3.06M | Sell |
108,721
-499
| -0.5% | -$14.2K | 0.75% | 28 |
|
|
2014
Q1 | $3.32M | Sell |
109,220
-3,612
| -3% | -$108K | 0.91% | 25 |
|
|
2013
Q4 | $3.28M | Buy |
+112,832
| New | +$3.28M | 1% | 20 |
|
Other funds holding PFE
VCM
VPM
Bank Hapoalim BM's PFE Position: Q1 2026 in Review
Bank Hapoalim BM increased its Pfizer (PFE) stake by 60% in Q1 2026, buying an estimated $1.09M and bringing the position to 109,495 shares worth $3.08M. The position accounts for 0.47% of the portfolio, ranked #33.
Bank Hapoalim BM first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $13.4M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bank Hapoalim BM held 109,495 shares of Pfizer worth $3.08M as of Q1 2026.
- Bank Hapoalim BM bought 41,100 Pfizer shares in Q1 2026, an estimated $1.09M.
- Pfizer made up 0.47% of Bank Hapoalim BM's portfolio in Q1 2026, its #33 holding.
- Bank Hapoalim BM first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
- Bank Hapoalim BM's Pfizer position peaked at $13.4M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bank Hapoalim BM's 13F filing for Q1 2026, filed 4 May 2026.